Surrozen (SRZN) Share-based Compensation Growth (1y) (2021 - 2026)
Surrozen (SRZN) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Surrozen |
225,877.86 |
-106.68 Mn |
- |
152.40% |
| Date | Value |
|---|
| Mar 31, 2026 |
152.40% |
| Dec 31, 2025 |
11.33% |
| Sep 30, 2025 |
-3.27% |
| Jun 30, 2025 |
-13.19% |
| Mar 31, 2025 |
-19.03% |
| Dec 31, 2024 |
-23.21% |
| Sep 30, 2024 |
13.80% |
| Jun 30, 2024 |
-1.12% |
| Mar 31, 2024 |
-8.77% |
| Dec 31, 2023 |
-24.14% |
| Sep 30, 2023 |
-15.23% |
| Jun 30, 2023 |
18.28% |
| Mar 31, 2023 |
23.25% |
| Dec 31, 2022 |
122.94% |
| Sep 30, 2022 |
74.84% |
| Jun 30, 2022 |
84.02% |
| Mar 31, 2022 |
92.84% |
| Dec 31, 2021 |
270.59% |
| Sep 30, 2021 |
340.00% |
